Skip to main content

HealthTimes

Health News

Zimbabwe Should Rethink Vaccine Deployment Strategy

Michael Gwarisa

ZIMBABWE has been urged to re-look its national vaccination distribution strategy in order to increase uptake and move close towards vaccinating at least 60 percent of the population. By Michael Gwarisa The country commenced vaccinating its citizens in March 2021 following a delivery of the Sinopharm doses from the Republic of China. Even though at

Read More
Features

#LongReadAhead: Vaccines Efficacy And Effectiveness Explained

healthTimesco

By Michael Gwarisa THE arrival of the coronavirus on our shores has to a larger extent planted an appetite for reading and commenting around health-related issues even amongst non-medical people. All of a sudden everyone is now a public health or medical analyst and this is largely due to information gaps present in our communities. The World Health

Read More
Dr Tinashe Gede
Features Health News

#LongReadAhead: Vaccines Efficacy And Effectiveness Explained

Michael Gwarisa

THE arrival of the coronavirus on our shores has to a larger extent planted an appetite for reading and commenting around health-related issues even amongst non-medical people. All of a sudden everyone is now a public health or medical analyst and this is largely due to information gaps present in our communities. By Michael Gwarisa

Read More
Health News

WHO Zimbabwe Expert Clarifies On Sinopharm Vaccine, Says Sinopharm And More Other Vaccines Awaiting WHO Emergency Use Approval

Michael Gwarisa

There is nothing unusual about Sinopharm being administered before getting the WHO SAGE approval Only Four Vaccines have received the WHO EUL approval SAGE likely to make recommendations to Sinopharm end of March or beginning of April THE Sinopharm, Sinovac, Suptnik and at least 30 more other vaccines have submitted their dossiers to the World

Read More